Risk factors associated with death in patients with severe respiratory syncytial virus infection

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 5, 2016, Pages 737-742

  Lee, Yen I ^a   Peng, Chun Chih ^a,b   Chiu, Nan Chang ^a,c   Huang, Daniel Tsung Ning ^a,d   Huang, Fu Yuan ^a   Chi, Hsin ^a,b,c,d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Down's syndrome; mortality; nosocomial infection; respiratory syncytial virus; risk factors

Indexed keywords

RIBAVIRIN; VIRUS ANTIGEN; ANTIVIRUS AGENT;

ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; CHILD; CHILDHOOD CANCER; CHILDHOOD MORTALITY; COMORBIDITY; DOWN SYNDROME; FEMALE; HEART VENTRICLE SEPTUM DEFECT; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; LOWER RESPIRATORY TRACT INFECTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NASOPHARYNGEAL ASPIRATION; NEUROLOGIC DISEASE; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PEDIATRIC INTENSIVE CARE UNIT; PREMATURITY; PRESCHOOL CHILD; PULMONARY HYPERTENSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; SCHOOL CHILD; TERTIARY CARE CENTER; THROAT CULTURE; VIRUS CULTURE; COMPLICATION; CROSS INFECTION; HOSPITALIZATION; MORTALITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDY; TAIWAN; VIROLOGY;

ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CROSS INFECTION; DOWN SYNDROME; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RIBAVIRIN; RISK FACTORS; TAIWAN; TERTIARY CARE CENTERS;

EID: 84923886645     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.08.020     Document Type: Article

References (38)

1. 1 Nair, H., Nokes, D.J., Gessner, B.D., Dherani, M., Madhi, S.A., Singleton, R.J., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375 (2010), 1545–1555.
2. 2 Berger, T.M., Aebi, C., Duppenthaler, A., Stocker, M., Swiss Pediatric Surveillance U. Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001–2005). Infection 37 (2009), 109–116.
3. 3 Leung, T.F., Lam, D.S., Miu, T.Y., Hon, K.L., Chau, C.S., Ku, S.W., et al. Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children. Infection 42 (2014), 343–350.
4. 4 Boyce, T.G., Mellen, B.G., Mitchel, E.F. Jr., Wright, P.F., Griffin, M.R., Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 137 (2000), 865–870.
5. 5 Wang, E.E., Law, B.J., Boucher, F.D., Stephens, D., Robinson, J.L., Dobson, S., et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 129 (1996), 390–395.
6. 6 Navas, L., Wang, E., de Carvalho, V., Robinson, J., Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 121 (1992), 348–354.
7. 7 Kristensen, K., Stensballe, L.G., Bjerre, J., Roth, D., Fisker, N., Kongstad, T., et al. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease. Arch Dis Child 94 (2009), 785–789.
8. 8 Hall, C.B., Weinberg, G.A., Iwane, M.K., Blumkin, A.K., Edwards, K.M., Staat, M.A., et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 360 (2009), 588–598.
9. 9 Hall, C.B., Powell, K.R., MacDonald, N.E., Gala, C.L., Menegus, M.E., Suffin, S.C., et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 315 (1986), 77–81.
10. 10 Milner, M.E., de la Monte, S.M., Hutchins, G.M., Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome. Am J Dis Child 139 (1985), 1111–1114.
11. 11 El Saleeby, C.M., Somes, G.W., DeVincenzo, J.P., Gaur, A.H., Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age. Pediatrics 121 (2008), 235–243.
12. 12 Shah, P.S., Hellmann, J., Adatia, I., Clinical characteristics and follow up of Down syndrome infants without congenital heart disease who presented with persistent pulmonary hypertension of newborn. J Perinat Med 32 (2004), 168–170.
13. 13 Freeman, S.B., Taft, L.F., Dooley, K.J., Allran, K., Sherman, S.L., Hassold, T.J., et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 80 (1998), 213–217.
14. 14 Zachariah, P., Ruttenber, M., Simoes, E.A., Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study. J Pediatr 160 (2012), 827–831.
15. 15 Uong, E.C., McDonough, J.M., Tayag-Kier, C.E., Zhao, H., Haselgrove, J., Mahboubi, S., et al. Magnetic resonance imaging of the upper airway in children with Down syndrome. Am J Respir Crit Care Med 163 (2001), 731–736.
16. 16 Bruijn, M., van der Aa, L.B., van Rijn, R.R., Bos, A.P., van Woensel, J.B., High incidence of acute lung injury in children with Down syndrome. Intensive Care Med 33 (2007), 2179–2182.
17. 17 Schloo, B.L., Vawter, G.F., Reid, L.M., Down syndrome: patterns of disturbed lung growth. Hum Pathol 22 (1991), 919–923.
18. 18 Murphy, M., Epstein, L.B., Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus. Clin Immunol Immunopathol 62 (1992), 245–251.
19. 19 Murphy, M., Lempert, M.J., Epstein, L.B., Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes. Am J Med Genet Suppl 7 (1990), 234–237.
20. 20 Kusters, M.A., Verstegen, R.H., Gemen, E.F., de Vries, E., Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 156 (2009), 189–193.
21. 21 de Hingh, Y.C., van der Vossen, P.W., Gemen, E.F., Mulder, A.B., Hop, W.C., Brus, F., et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 147 (2005), 744–747.
22. 22 Murphy, M., Epstein, L.B., Decreased T cell receptor and CD3 expression by Down syndrome thymocytes: evidence for delayed maturation. Prog Clin Biol Res 360 (1990), 117–130.
23. 23 Licastro, F., Melotti, C., Parente, R., Davis, L.J., Chiricolo, M., Zannotti, M., et al. Derangement of non-specific immunity in Down syndrome subjects: low leukocyte chemiluminescence activity after phagocytic activation. Am J Med Genet Suppl 7 (1990), 242–246.
24. 24 Loh, R.K., Harth, S.C., Thong, Y.H., Ferrante, A., Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J 9 (1990), 547–551.
25. 25 Thorburn, K., Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 94 (2009), 99–103.
26. 26 Buckingham, S.C., Quasney, M.W., Bush, A.J., DeVincenzo, J.P., Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med 2 (2001), 318–323.
27. 27 Thorburn, K., Kerr, S., Taylor, N., van Saene, H.K., RSV outbreak in a paediatric intensive care unit. J Hosp Infect 57 (2004), 194–201.
28. 28 Purcell, K., Fergie, J., Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J 23 (2004), 418–423.
29. 29 Hall, C.B., Douglas, R.G. Jr., Geiman, J.M., Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis 132 (1975), 151–156.
30. 30 Katzov-Eckert, H., Botosso, V.F., Neto, E.A., Zanotto, P.M., Consortium V. Phylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in children. PLoS One, 7, 2012, e41953.
31. 31 Ventre, K., Randolph, A., Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev, 2004, CD000181.
32. 32 Smith, D.W., Frankel, L.R., Mathers, L.H., Tang, A.T., Ariagno, R.L., Prober, C.G., A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 325 (1991), 24–29.
33. 33 Rodriguez, W.J., Kim, H.W., Brandt, C.D., Fink, R.J., Getson, P.R., Arrobio, J., et al. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infect Dis J 6 (1987), 159–163.
34. 34 Hall, C.B., McBride, J.T., Walsh, E.E., Bell, D.M., Gala, C.L., Hildreth, S., et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med 308 (1983), 1443–1447.
35. 35 Meert, K.L., Sarnaik, A.P., Gelmini, M.J., Lieh-Lai, M.W., Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit Care Med 22 (1994), 566–572.
36. 36 Moler, F.W., Steinhart, C.M., Ohmit, S.E., Stidham, G.L., Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. J Pediatr 128 (1996), 422–428.
37. 37 Guerguerian, A.M., Gauthier, M., Lebel, M.H., Farrell, C.A., Lacroix, J., Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 160 (1999), 829–834.
38. 38 Groothuis, J., Bauman, J., Malinoski, F., Eggleston, M., Strategies for prevention of RSV nosocomial infection. J Perinatol 28 (2008), 319–323.